Market Size of Insulin Glargine Industry
Study Period | 2018 - 2029 |
Market Size (2024) | USD 1.54 Billion |
Market Size (2029) | USD 2.09 Billion |
CAGR (2024 - 2029) | 6.28 % |
Fastest Growing Market | North America |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Insulin Glargine Market Analysis
The Insulin Glargine Market size is estimated at USD 1.54 billion in 2024, and is expected to reach USD 2.09 billion by 2029, growing at a CAGR of 6.28% during the forecast period (2024-2029).
The COVID-19 pandemic has resulted in a surge in diabetic complexities, which is driving the insulin demand in the market. Type 1 diabetes can be characterized as insulin-requiring, while Type 2 diabetes can be characterized as insulin-dependent diabetes. People with diabetes have a 300% increased risk of being hospitalized compared to those without diabetes, and, thus, they incur more healthcare expenses than non-diabetic people. Patients with Type 2 diabetes require many corrections throughout the day to maintain nominal blood glucose levels, such as the administration of additional insulin or ingestion of additional carbohydrates. Achieving nominal results can be very difficult without multiple daily injections of insulin or insulin pump therapy. This is driving the demand for insulin on a global scale, which is expected to drive the market studied during the forecast period.